Nucleic Acid Therapeutics Market Size And Share

Report Code : TIPRE00027648
Category : Life Sciences

No. of Pages : 150

Buy Now

Principales conclusions et analyse des parts de marché des thérapies par acides nucléiques d'ici 2025-2031

Buy Now

Nucleic Acid Therapeutics Market Report Analysis

Nucleic Acid Therapeutics Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Alnylam Pharmaceuticals, Inc.
Silence Therapeutics plc
Arbutus Biopharma Corporation
Genzyme (Sanofi)
Ionis Pharmaceuticals
Sarepta Therapeutics
Benitec Biopharma Inc.
Arrowhead Pharmaceuticals
Biogen, Inc.

Regional Overview

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et centrale
Moyen-Orient et Afrique

Market Segmentation

By Type

Antagomir et éponge d'ARN
thérapie oligonucléotidique antisens
acide nucléique verrouillé
oligoacide nucléique peptidique
thérapie ARNi
oligonucléotide formant triplex.

By Application

troubles génétiques
troubles auto-immunes

By Utilisateur final

instituts de recherche
hôpitaux et cliniques.

By Géographie

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et Centrale